ABEONA THERAPEUTICS INC.

ABEO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2010
Revenue $481.0K
Cost of Revenue $140.0K
Gross Profit $341.0K
Gross Margin 70.9%
Operating Expenses
Research & Development $3.3M
SG&A Expense $4.5M
Operating Income $-7.8M
Operating Margin -1,612.7%
Interest Expense
Pretax Income $-7.5M
Income Tax Expense $0
Net Income $-7.5M
Net Margin -1,566.9%
EPS (Basic) $0.00
EPS (Diluted) $0.00
Shares Outstanding (Basic)
Shares Outstanding (Diluted)
Dividends Per Share
← Newer Page 3 of 3 Older →